Extraordinary General Meeting of Shareholders in NIBE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Extraordinary General Meeting of Shareholders in NIBE Industrier AB

Markaryd, Sweden, 2016-10-04 08:00 CEST (GLOBE NEWSWIRE) --

Gerteric Lindquist, Managing Director and CEO, informed shareholders about the background and the reasons to the preferential rights issue that was carried out in order to maintain continued strong acquisition capacity and thereby continue to realise NIBE’s growth strategy. Full subscription of the rights issue will inject approximately SEK 3,024 million into NIBE Industrier AB and the company’s share capital will increase from SEK 68,908,523.75 to approximately SEK 78,752,598.44.

The number of shares in NIBE is expected to increase from a total of 441,014,552, of which 51,741,024 are class A shares and 389,273,528 are class B shares, to a maximum of 504,016,630 shares, of which 59,132,598 are class A shares and 444,884,032 are class B shares.

The Extraordinary General Meeting further resolved to amend paragraphs 4 and 5 (limits to share capital and number of shares) of the articles of association, which is a prerequisite for the implementation of the rights issue. The wording of paragraph 4 is changed from “The share capital shall be not less than forty million (40,000,000) SEK and not more than eighty million (80,000,000) SEK” to “The share capital shall be not less than sixty-two million five hundred thousand (62,500,000) SEK and not more than one hundred and twenty-five million (125,000,000) SEK”. The wording of paragraph 5 is changed from “The number of shares shall be not less than two hundred and fifty-six million (256,000,000) and not more than five hundred and twelve million (512,000,000)” to “The number of shares shall be not less than four hundred million (400,000,000) and not more than eight hundred million (800,000,000)”.

For more information on the rights issue, please refer to previous press releases from the company issued on 12 May, 31 August and 27 September 2016.

This information is information that NIBE Industrier AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of Benny Torstensson on October 4, 2016 at 08:00 CET.

Benny Torstensson, Information manager: +46 (0)433-73 070

Christel Fritiofsson, Investor Relations: +46 (0)433-73 078

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 87

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 119

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 177

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 38

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading

Top 5 Most Recently Viewed Articles

MiMedx Group Q4 Earnings: Impressive Beat Raises Eyebrows

Updated Category News Views 262

What a Turnaround! Numbers don’t lie, right? Well, take a look at MiMedx Group (NASDAQ:MDXG) and you see a company that’s done some real transformation. Their Q4 report came out on February 25, 2026, and it’s hard not to be impressed. They smashed the earnings estimate—by a whopping 40%. That’s no small feat in this market, especially when you look at the EPS...

Continue Reading
Intuitive Machines Sets Financial Results Conference Call Date

Updated Category News Views 132

Intuitive Machines Schedules Conference Call for Financial Results Intuitive Machines, Inc. (Nasdaq: LUNR) has made an important announcement regarding its upcoming financial results. The company is set to release its fourth quarter and full-year financial outcomes, providing an in-depth look at its performance for 2024. This announcement will be made on a specific date...

Continue Reading
OSB Group PLC: Insights into the Latest Block Listing Return

Updated Category News Views 326

Understanding OSB Group PLC's Block Listing Return In the ever-evolving landscape of financial markets, regular disclosures play a pivotal role in maintaining transparency. Here, we delve into the latest block listing return from OSB Group PLC, outlining crucial details in a clear and concise manner. Key Details of the Block Listing Return It's essential for stakeholders...

Continue Reading
Gemini Expands its Offerings with Tokenized U.S. Equities

Updated Category News Views 342

Gemini Launches Tokenized U.S. Equities In an exciting development for European investors, Gemini has expanded its offerings by facilitating the trading of tokenized U.S. equities. This marks a significant shift in providing easier access to international investment opportunities. Initially launched for its user base in Europe, Gemini aims to create a seamless experience...

Continue Reading
Vivian Health Welcomes New CEO Bill Kong for Future Growth

Updated Category News Views 125

Vivian Health's New Era with CEO Bill Kong Vivian Health, a prominent player in the healthcare jobs marketplace, is transitioning into a new chapter under the leadership of Bill Kong, who has been appointed as the CEO. This strategic move follows the remarkable success achieved by Parth Bhakta, co-founder and outgoing CEO, who now assumes the role of Executive Chairman....

Continue Reading